The global endoscopy operative devices market size reached a value of USD 10.34 billion in 2023 and is projected to grow at a CAGR of 5.3% from 2024 to 2030. The increasing prevalence of chronic diseases, particularly among the elderly population, is a major driver of market growth. Conditions such as gallstones, liver abscesses, pelvic abscesses, intestinal perforation, and endometriosis often require endoscopic intervention, resulting in a growing demand for endoscopy operative devices.
The shift to minimally invasive procedures is another key factor accelerating market growth. Endoscopic procedures offer numerous advantages, including reduced post-operative pain and complications, faster recovery, lighter anesthesia, and shorter hospital stays. This trend is expected to continue as patients and healthcare providers increasingly recognize the benefits of minimally invasive procedures. Technological advancements in endoscopic devices are also driving market growth, enabling better visualization and treatment while reducing the cost of procedures.
The favorable demographics of the global population are also contributing to market growth. According to the UN, by 2050, the global population aged 60 years and above is projected to double to its current value, representing approximately 22.0% of the total population. This demographic shift is expected to drive demand for endoscopic procedures as the elderly population is more prone to chronic diseases requiring endoscopic intervention. Furthermore, the growing awareness of the advantages of minimally invasive procedures is contributing to the rising demand for endoscopies.
The increasing demand for gastrointestinal endoscopy is also expected to drive market growth. This trend is driven by the rising prevalence of gastrointestinal disorders globally. The growing number of healthcare centers and the upgrading of healthcare infrastructure in developed and emerging economies are also leading to an increase in demand for endoscopes and operative devices.
Reusable operative devices led the market in 2023, accounting for a revenue share of 82.0%, fueled by their cost-effectiveness, improved durability, and performance. Healthcare providers are drawn to this option as it enables better visualization and maneuverability during procedures, while also aligning with the growing demand for minimally invasive surgeries. The increasing geriatric population and associated chronic diseases are further driving demand for reusable operative devices.
Disposable operative devices are projected to grow at the fastest CAGR of 6.1% over the forecast period, driven by concerns about infection control and cross-contamination risks associated with reusable devices. The COVID-19 pandemic accelerated this trend, as healthcare facilities sought to minimize infection risks. Advancements in technology have enabled the development of high-quality disposable endoscopes with comparable performance, while minimally invasive procedures also contribute to the segment’s growth.
North America endoscopy operative devices market accounted for the largest revenue share of over 40.0% in the global endoscopy operative devices market in 2023. Market growth in the region is aided by its advanced healthcare infrastructure, widespread adoption of cutting-edge technologies, and high prevalence rates of gastrointestinal disorders and chronic diseases. The growing geriatric population and emphasis on minimally invasive surgeries, which offer reduced recovery times and lower complication rates, also contribute to the region’s market dominance.
The endoscopy operative devices market in the U.S. dominated the North America endoscopy operative devices market with a share of over 90.0% in 2023. Market growth in the country is driven by the growing preference for minimally invasive procedures, offering benefits such as reduced post-operative pain and shorter recovery times. Advancements in endoscopic technology, high healthcare expenditure, and the presence of key manufacturers such as Olympus and Boston Scientific contribute to the market’s growth.
Europe endoscopy operative devices market is anticipated to grow lucratively over the forecast period, owing to its advanced healthcare infrastructure, strong regulatory framework, and growing demand for minimally invasive surgeries. The increasing prevalence of chronic diseases and aging population, particularly vulnerable to age-related ailments, fuel demand. Technological advancements in imaging and device design also contribute to growth.
The endoscopy operative devices market in Germany is driven by its focus on technological innovation and medical device advancements, resulting in sophisticated endoscopic solutions. The growing prevalence of chronic diseases, particularly gastrointestinal disorders, requires more endoscopic procedures. Minimally invasive surgeries’ benefits, such as reduced recovery times, drive demand. Germany’s robust healthcare infrastructure and high expenditure support market growth.
Asia Pacific endoscopy operative devices market is anticipated to register the fastest growth of 7.3% in the global endoscopy operative devices market between 2024 and 2030. Factors such as increasing disposable incomes, improved healthcare infrastructure, and advanced endoscopic techniques are contributing to industry growth in the region. Global players are expanding their presence through distribution agreements and local manufacturing facilities.
The endoscopy operative devices market in Japan is driven by its aging population, with a high proportion of elderly individuals, leading to a rising demand for age-related disease treatment. The country’s technological innovation and emphasis on regulatory quality and safety standards ensure high-quality devices. Minimally invasive surgeries adoption and robust healthcare infrastructure further boost market growth.
Some key companies in the endoscopy operative devices market include Cook; Medtronic; CONMED Corporation; Boston Scientific Corporation; and Medical Device Business Services, Inc.; among others. Manufacturers are adopting strategies such as technological collaborations, acquisitions, and expanded product portfolios to enhance their market position.
Stryker offers medical technologies and surgical instruments to enhance surgical precision and patient outcomes. Its extensive product portfolio and commitment to R&D drive growth in minimally invasive procedures.
Richard Wolf GmbH is a developer and manufacturer of high-quality endoscopic instruments and systems. The company focuses on minimally invasive procedures and user-friendly technology.
The following are the leading companies in the endoscopy operative devices market. These companies collectively hold the largest market share and dictate industry trends.
View a comprehensive list of companies in the Endoscopy Operative Devices Market
In July 2024, Merit Medical Systems acquired EndoGastric Solutions’ EsophyX Z+ device for USD 105.00 million, expanding its endoscopy portfolio and enhancing its global footprint in the gastrointestinal market.
In April 2024, Medtronic unveiled the future of AI in GI at the Genius Summit 2024, introducing ColonPRO™ software for the GI Genius™ intelligent endoscopy system and a strategic collaboration with ModMed to enhance patient care.
In April 2024, KARL STORZ acquired the business of a distributor in Belgium, Luxembourg, and the Netherlands- Stöpler-expanding its direct sales presence in the region.
In January 2024, Canon Medical Systems and Olympus announced a business alliance to develop and market Endoscopic Ultrasound Systems, combining Canon’s advanced diagnostic ultrasound technology with Olympus’ endoscope expertise.
Report Attribute |
Details |
Market size value in 2024 |
USD 10.77 billion |
Revenue forecast in 2030 |
USD 14.69 billion |
Growth rate |
CAGR of 5.3% from 2024 to 2030 |
Base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, region |
Regional scope |
North America, Europe, Asia Pacific, Latin America, MEA |
Country scope |
U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, Japan, China, India, Australia, South Korea, Thailand, Brazil, Argentina, South Africa, Saudi Arabia, UAE, Kuwait |
Key companies profiled |
Cook; Medtronic; CONMED Corporation; Boston Scientific Corporation; Medical Device Business Services, Inc.; Stryker; KARL STORZ SE & Co. KG; Richard Wolf GmbH; FUJIFILM Corporation; Olympus; Smith+Nephew; BD |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research, Inc. has segmented the global endoscopy operative devices market report on the basis of product and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Reusable Operative Devices
Energy Systems
Access Devices
Suction & Irrigation Systems
Hand Instruments
Wound Retractors
Snares
Disposable Operative Devices
Energy Systems
Access Devices
Suction & Irrigation Systems
Hand Instruments
Wound Retractors
Snares
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."